Exact Mass: 424.0118376
Exact Mass Matches: 424.0118376
Found 76 metabolites which its exact mass value is equals to given mass value 424.0118376
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Quercetin 7,3,4-trimethyl ether 3-sulfate
C18H16O10S (424.04641560000005)
Mikanin 3-O-sulfate
C18H16O10S (424.04641560000005)
2-Hydroxy-3-chlordiospyrin|3-Chloro, 2-hydroxy-Diospyrin
C22H13ClO7 (424.03497780000004)
2-[2-(acetylamino)-4-amino-5-methoxyphenyl]-5-amino-7-bromo-4-chloro-2H-benzotriazole
Thiamin diphosphate
C12H18N4O7P2S (424.03714180000003)
4-(5-Bromo-thiophene-2-sulfonyl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester
C14H21BrN2O4S2 (424.01260460000003)
1H-Pyrrolo[2,3-b]pyridine-1-carboxylic acid, 3-iodo-5-(1-Methyl-1H-pyrazol-4-yl)-, 1,1-dimethylethyl ester
1,8-Bis(phenylthio)anthracene-9,10-dione
C26H16O2S2 (424.05916759999997)
2-Naphthalenecarboxylic acid, 3-hydroxy-4-(4-methyl-3-sulfophenyl)azo-, calcium salt
(3S,4R)-METHYL 3-(4-CHLOROBENZOYL)-6-(4-CHLOROPHENYL)-3,4,5-TRIHYDROXY-6-OXOHEXANOATE
rac-Ethylenebis(4,5,6,7-tetrahydro-1-indenyl)]zirconium dichloride
rac-ethylenebis(4,5,6,7-tetrahydro-1-indenyl)zirconium dichloride
4,5-Dihydroxy-3-(phenyldiazenyl)naphthalene-2,7-disulfonic acid
2-(1,3-Benzodioxol-5-ylmethylthio)-5-(2-furanyl)-3-prop-2-enyl-4-thieno[2,3-d]pyrimidinone
2-[(3-Hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl)-imino]-5-phosphono-pent-3-enoic acid
Adenosine-diphosphate
COVID info from COVID-19 Disease Map, WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[(Z)-[2-(4-hydroxyphenyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylethylidene]amino] sulfate
C14H18NO10S2- (424.03721079999997)
N-(3,5-dichloro-2-pyridinyl)-2-[[1-(2-methoxyethyl)-2-benzimidazolyl]thio]propanamide
N-(3-chlorophenyl)-4-fluoro-3-(thiophen-2-ylmethylsulfamoyl)benzamide
ADP(3-)
A nucleoside 5-diphosphate(3-) arising from deprotonation of all three diphosphate OH groups of adenosine 5-diphosphate (ADP); major species present at pH 7.3.
dGDP(3-)
A 2-deoxyribonucleoside 5-diphosphate obtained by deprotonation of the diphosphate OH groups of dGDP.
8-oxo-dADP(3-)
An organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups of 8-oxo-dADP.
thiamine(1+) diphosphate(1-)
C12H18N4O7P2S (424.03714180000003)
An ammonium betaine that is the conjugate base of thiamine(1+) diphosphate arising from the deprotonation of one of the hydroxy groups of the terminal phosphate group.
NP-1815-PX (sodium)
C21H13N4NaO3S (424.0606028000001)
NP-1815-PX sodium is a potent and selective P2X4R antagonist. NP-1815-PX sodium has anti-inflammatory activity, and can relieve pain in chronic pain models. NP-1815-PX sodium also inhibits guinea pig tracheal/bronchial smooth muscle (TSM and BSM) contractions[1][2][3].
(2r,5s,7s)-2-(1-bromopropyl)-5,7-dichloro-8-[(2e)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
2-(1-bromopropyl)-5,7-dichloro-8-(pent-2-en-4-yn-1-yl)oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(2r,4s,5s,7s,8s)-2-[(1s)-1-bromopropyl]-5,7-dichloro-8-[(2e)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(2r,3r,5e)-1-[(2s,3s,5r,6r)-5-bromo-3-chloro-6-ethyloxan-2-yl]-3-chlorooct-5-en-7-yn-2-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(5e)-1-[(2r,3r,5r,6s)-5-bromo-3-chloro-6-ethyloxan-2-yl]-3-chlorooct-5-en-7-yn-2-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(2r,4s,5s,7s,8s)-2-[(1s)-1-bromopropyl]-5,7-dichloro-8-[(2z)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
2-(1-bromopropyl)-5,7-dichloro-8-[(2e)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(5r,6r)-3-{2-[(1-hydroxyethylidene)amino]ethanesulfinyl}-7-oxo-6-[2-(sulfooxy)propan-2-yl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C14H20N2O9S2 (424.06101900000004)
3-(3,3-dichloro-2-methylpropyl)-1,4-dimethyl-6-(3,3,3-trichloro-2-methylpropyl)piperazine-2,5-dione
(3s,6s)-3-[(2s)-3,3-dichloro-2-methylpropyl]-1,4-dimethyl-6-[(2s)-3,3,3-trichloro-2-methylpropyl]piperazine-2,5-dione
(2s,3ar,5r,7s,8r,9ar)-2-(3-bromopropa-1,2-dien-1-yl)-5-(1-bromopropyl)-octahydro-2h-furo[3,2-b]oxocine-7,8-diol
(5r,6r)-3-[(r)-2-[(1-hydroxyethylidene)amino]ethanesulfinyl]-7-oxo-6-[2-(sulfooxy)propan-2-yl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C14H20N2O9S2 (424.06101900000004)
(2s,3r,4s,5s,7r)-3-(bromomethyl)-5-chloro-7-[(1r,3z)-1-chlorohex-3-en-5-yn-1-yl]-2-ethyloxepan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(2r,4s,5s,7s,8s)-2-[(1r)-1-bromopropyl]-5,7-dichloro-8-[(2z)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
3-(bromomethyl)-5-chloro-7-(1-chlorohex-3-en-5-yn-1-yl)-2-ethyloxepan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(2r,4s,5s,7s,8s)-2-[(1r)-1-bromopropyl]-5,7-dichloro-8-(pent-2-en-4-yn-1-yl)oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
6,7,8,17,18-pentahydroxy-3,10,15,22-tetraoxahexacyclo[14.6.2.0²,¹¹.0⁴,⁹.0¹³,²³.0²⁰,²⁴]tetracosa-1,4,6,8,11,13(23),16(24),17,19-nonaene-14,21-dione
(2s,3ar,5r,7s,8r,9ar)-2-(3-bromopropa-1,2-dien-1-yl)-5-[(1r)-1-bromopropyl]-octahydro-2h-furo[3,2-b]oxocine-7,8-diol
(2s,3ar,5r,7s,8r,9ar)-2-(3-bromopropa-1,2-dien-1-yl)-5-[(1s)-1-bromopropyl]-octahydro-2h-furo[3,2-b]oxocine-7,8-diol
(2r,4s,5s,7s,8s)-2-[(1r)-1-bromopropyl]-5,7-dichloro-8-[(2e)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
3-[(4-imino-2-methyl-3h-pyrimidin-5-yl)methyl]-4-methyl-5-{2-[(phosphono phosphonato)oxy]ethyl}-1,3-thiazol-3-ium
C12H18N4O7P2S (424.03714180000003)
(3r,6r)-3-[(2r)-3,3-dichloro-2-methylpropyl]-1,4-dimethyl-6-[(2s)-3,3,3-trichloro-2-methylpropyl]piperazine-2,5-dione
(4s,5s,7s,8s)-2-[(1r)-1-bromopropyl]-5,7-dichloro-8-[(2z)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)